Axsome Therapeutics, Inc. (AXSM)
Nasdaq: AXSM · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2013
Who owns Axsome Therapeutics, Inc.
As filed with the SECHolders of 5% or more
1
Blackrock, Inc. holds 5.3% of Common Stock, as its SCHEDULE 13G/A filed Jul 27, 2026 says.
Directors and officers
9
report now, of 13 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 27, 2026 · Common Stock
RTW Investments, LP
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 6% in May 15, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What AXSM reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Baergic Bio, Inc.
A company bought · acquisition · owns, named in the 10-K filed Feb 23, 2026
Sunosi
A company bought · acquisition · owns, named in the 10-K filed Feb 23, 2026
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 23, 2026.
Insider tradesForm 4
36sales
0purchases
36sales on a scheduled plan
8people selling
$140Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Tabuteau Herriot | Chief Executive Officer | 17 | $103M | 17 | 0 | $0 |
| Pizzie Nick | Chief Financial Officer | 2 | $10.2M | 2 | 0 | $0 |
| Jacobson Mark L. | Chief Operating Officer | 4 | $8.9M | 4 | 0 | $0 |
| Coleman Mark | director | 5 | $8.2M | 5 | 0 | $0 |
| Saad Mark E | director | 2 | $6.2M | 2 | 0 | $0 |
| Maizel Ari | Chief Commercial Officer | 2 | $2.8M | 2 | 0 | $0 |
| Jeffs Roger | director | 2 | $100,000 | 2 | 0 | $0 |
| Mahony Susan | director | 2 | $100,000 | 2 | 0 | $0 |